Stocklytics Platform
Asset logo for symbol VSTM
Verastem
VSTM57
$2.88arrow_drop_up1.76%$0.05
Penny Stock
Asset logo for symbol VSTM
VSTM57

$2.88

arrow_drop_up1.76%

Performance History

Chart placeholder
Key Stats
Open$2.83
Prev. Close$2.83
EPS-3.21
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$115.90M
PE Ratio-
LOWHIGH
Day Range2.74
2.99
52 Week Range2.10
14.22
Ratios
Revenue-
EBITDA Margin %-
EPS-3.21

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Verastem (VSTM)

Verastem Inc (VSTM) is a biopharmaceutical company focused on developing and commercializing drugs to treat cancer patients. The company's lead product candidate, Duvelisib, is a dual inhibitor of PI3K-delta and PI3K-gamma, which are enzymes that are involved in the growth and survival of cancer cells. Duvelisib has shown promising results in clinical trials and is currently being evaluated for the treatment of various hematologic malignancies, including chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL).
In addition to Duvelisib, Verastem is also developing several other product candidates, including defactinib, which is an inhibitor of focal adhesion kinase (FAK), and VS-4718, which is a dual inhibitor of focal adhesion kinase (FAK) and the PI3K-delta isoform. These product candidates have shown potential in preclinical and early clinical studies, and Verastem is actively advancing their development.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Daniel W. Paterson
Headquarters
Needham
Employees
57
Exchange
NASDAQ
add Verastem  to watchlist

Keep an eye on Verastem

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Verastem 's (VSTM) price per share?

The current price per share for Verastem (VSTM) is $2.88. The stock has seen a price change of $0.05 recently, indicating a 1.77% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Verastem (VSTM)?

For Verastem (VSTM), the 52-week high is $14.22, which is 393.75% from the current price. The 52-week low is $2.1, the current price is 37.14% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Verastem (VSTM) a growth stock?

Verastem (VSTM) has shown an average price growth of 0.41% over the past three years. It has received a score of 46 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Verastem as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Verastem (VSTM) stock price performance year to date (YTD)?

As of the latest data, Verastem (VSTM) has a year-to-date price change of -65.3%. Over the past month, the stock has experienced a price change of 15.66%. Over the last three months, the change has been -11.38%. Over the past six months, the figure is -74.54%. Looking at a longer horizon, the five-year price change stands at -81.54%.
help

Is Verastem (VSTM) a profitable company?

Verastem (VSTM) has a net income of -$87.37M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -182.77% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$92.08M. Furthermore, the EBITDA is -$98.76M.
help

What is the market capitalization of Verastem (VSTM)?

Verastem (VSTM) has a market capitalization of $115.9M. The average daily trading volume is 611.6K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media